Skip to content

Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2

Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03168191
Enrollment
56
Registered
2017-05-30
Start date
2017-05-02
Completion date
2019-02-25
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence

Brief summary

This study is to examine if inhaled doses of an e-cigarette flavor, alone and in combination with menthol, changes the appeal of e-cigarettes containing low and high doses of nicotine. The hypothesis is that menthol and the other experimental flavor will interact with nicotine dose to improve taste and liking for e-cigarettes.

Interventions

DRUGNicotine

Participants will receive low dose nicotine (6 mg/ml) or high dose nicotine (12 mg/ml)

OTHERExperimental Flavor

Experimental fruit flavored e-cigarette for lab session

Menthol flavored e-cigarette for lab session

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 18-20 years * Able to read and write * Urine cotinine levels of \>250 ng/ml at screening appointment * Use of e-cigarettes in the past month * May or may not currently smoke traditional cigarettes

Exclusion criteria

* Seeking smoking cessation treatment * Current/lifetime criteria for dependence on another psychoactive substance -Daily use of alcohol or marijuana or use of any other drugs including cocaine, opiates, stimulants * Regular use of psychoactive drugs including anxiolytics, antidepressants and other psychostimulants * Current or past history of psychosis or other psychiatric diagnosis such as major depression * Any significant current medical condition

Design outcomes

Primary

MeasureTime frameDescription
Change score in Liking/wanting of the e-cigaretteBaseline (+10 minutes) to end of lab session (+40 minutes)The Drug Effects Questionnaire (Soria et al) will be used to ask about liking and wanting during the lab session

Secondary

MeasureTime frameDescription
Change score in rating of harshness/irritationBaseline (+10 minutes) to end of lab session (+40 minutes)gMLS rating of e-cigarette harshness/irritation
Change score in rating of sweetnessBaseline (+10 minutes) to end of lab session (+40 minutes)gMLS rating of e-cigarette sweetness
Change score in rating of sournessEnd of lab session (+40 minutes)gMLS rating of e-cigarette sourness
Change score in rating of fruitinessBaseline (+10 minutes) to end of lab session (+40 minutes)gMLS rating of e-cigarette fruitiness
Change score in rating of coolnessBaseline (+10 minutes) to end of lab session (+40 minutes)gMLS rating of e-cigarette coolness
E-cigarette valueBaseline (+10 minutes) to end of lab session (+40 minutes)Value of e-cigarette as determined by the Multiple Choice Questionnaire (MCP) task
Number of puffsEnd of ad-lib lab session 4 (+40 minutes)Number of puffs taken at the end of the ad-lib vaping period
Change score in Tobacco CravingBaseline (+10 minutes) to end of lab session (+40 minutes)The Brief Questionnaire on Smoking Urges (Tiffany & Drobes,1991) will be used to assess the magnitude of change in tobacco craving during the lab session
Change score in rating of total sensationBaseline (+10 minutes) to end of lab session (+40 minutes)gMLS rating of e-cigarette total sensation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026